AQR Capital Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $615K | Sell |
27,722
-2,289
| -8% | -$50.8K | ﹤0.01% | 2493 |
|
2025
Q1 | $558K | Buy |
30,011
+18,165
| +153% | +$338K | ﹤0.01% | 2365 |
|
2024
Q4 | $157K | Sell |
11,846
-36,746
| -76% | -$487K | ﹤0.01% | 2711 |
|
2024
Q3 | $1.63M | Buy |
+48,592
| New | +$1.63M | ﹤0.01% | 1590 |
|
2024
Q2 | – | Sell |
-24,328
| Closed | -$548K | – | 2601 |
|
2024
Q1 | $548K | Buy |
24,328
+7,646
| +46% | +$172K | ﹤0.01% | 1931 |
|
2023
Q4 | $357K | Buy |
+16,682
| New | +$357K | ﹤0.01% | 2006 |
|
2022
Q2 | – | Sell |
-38,833
| Closed | -$961K | – | 2178 |
|
2022
Q1 | $961K | Sell |
38,833
-169
| -0.4% | -$4.18K | ﹤0.01% | 1562 |
|
2021
Q4 | $1.36M | Buy |
39,002
+12,657
| +48% | +$440K | ﹤0.01% | 1402 |
|
2021
Q3 | $714K | Buy |
26,345
+11,712
| +80% | +$317K | ﹤0.01% | 1726 |
|
2021
Q2 | $379K | Sell |
14,633
-8,541
| -37% | -$221K | ﹤0.01% | 1980 |
|
2021
Q1 | $499K | Sell |
23,174
-36,894
| -61% | -$794K | ﹤0.01% | 1837 |
|
2020
Q4 | $1.29M | Buy |
+60,068
| New | +$1.29M | ﹤0.01% | 1386 |
|
2019
Q1 | – | Sell |
-4,442
| Closed | -$283K | – | 2159 |
|
2018
Q4 | $283K | Sell |
4,442
-8,045
| -64% | -$513K | ﹤0.01% | 1982 |
|
2018
Q3 | $1.25M | Sell |
12,487
-20,938
| -63% | -$2.09M | ﹤0.01% | 1611 |
|
2018
Q2 | $2.38M | Buy |
33,425
+16,185
| +94% | +$1.15M | ﹤0.01% | 1347 |
|
2018
Q1 | $1.79M | Buy |
+17,240
| New | +$1.79M | ﹤0.01% | 1402 |
|